Dried Blood Spot Methodology in Combination With Liquid Chromatography/Tandem Mass Spectrometry Facilitates the Monitoring of Teriflunomide

BACKGROUND: Teriflunomide, a once-daily oral immunomodulator approved for treatment of relapsing-remitting multiple sclerosis, is eliminated slowly from plasma. If necessary to rapidly lower plasma concentrations of teriflunomide, an accelerated elimination procedure using cholestyramine or activate...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ther Drug Monit
Main Authors: Filali-Ansary, Aziz, Lunven, Catherine, Turpault, Sandrine, Beyer, Yann-Joel, O'Brien, Amy, Delfolie, Astrid, Boyanova, Neli, Sanderink, Ger-Jan, Baldinetti, Francesca
Formato: Artigo
Idioma:Inglês
Publicado em: Therapeutic Drug Monitoring 2016
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4949010/
https://ncbi.nlm.nih.gov/pubmed/27015245
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FTD.0000000000000302
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados